Skip to main content
Year archive

Gentian Diagnostics ASA — 2021 filings

All 54 regulatory filings released by Gentian Diagnostics ASA (GENT) in 2021, sourced directly from the official regulator.

54 Filings
2021 Period
2021 filings (54)
Filing Released Lang
Financial calendar
Report Publication Announcement
2021-12-16 English
Completed development of SARS Cov-2 antibody assay
Regulatory Filings
2021-12-16 English
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference
Investor Presentation
2021-12-16 English
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference
Report Publication Announcement
2021-12-16 English
Share capital increase registered - Correction*
Share Issue/Capital Change
2021-12-10 English
Share capital increase registered
Share Issue/Capital Change
2021-12-09 English
Mandatory notification of trade
Director's Dealing
2021-11-30 English
Mandatory notification of trade
Remuneration Information
2021-11-30 English
Share Issue in Connection with Employee Share Purchase Program
Share Issue/Capital Change
2021-11-29 English
Multicenter study confirms calprotectin’s role in risk stratification in COVID-19
Environmental & Social Information
2021-11-03 English
Multicenter study confirms calprotectin’s role in risk stratification in COVID-19
Report Publication Announcement
2021-11-03 English
New study supports the value of calprotectin in management of COVID-19 patients
Environmental & Social Information
2021-11-01 English
New study supports the value of calprotectin in management of COVID-19 patients
Regulatory Filings
2021-11-01 English
Third quarter 2021 financial report
Investor Presentation
2021-10-21 English
Third quarter 2021 financial report
Interim / Quarterly Report Q3 2021
2021-10-21 English
Third quarter 2021 financial report
Earnings Release Q3 2021
2021-10-21 English
Flaggemelding
Director's Dealing
2021-10-11 Norwegian
Product and market developments update
Regulatory Filings
2021-10-05 English
Product and market developments update
Regulatory Filings
2021-10-05 English
Invitation to presentation of third quarter results
Report Publication Announcement
2021-10-05 English
Norron Sicav Flagging i Gentian Diagnostics ASA
Major Shareholding Notification
2021-09-08 Norwegian
Flaggemelding, Salix AS - Gentian Diagnostics ASA
Major Shareholding Notification
2021-08-26 Norwegian
Mandatory notification of trade and disclosure of large shareholding
Director's Dealing
2021-08-25 English
Mandatory notification of trade and disclosure of large shareholding
Major Shareholding Notification
2021-08-25 English
Second quarter 2021 report
Earnings Release H1 2021
2021-08-25 English
Second quarter 2021 report
Investor Presentation
2021-08-25 English
Second quarter 2021 report
Earnings Release Q2 2021
2021-08-25 English
Invitation to presentation of second quarter results
Report Publication Announcement
2021-08-19 English
Gentian Diagnostics ASA – Approval and publication of prospectus, and transfer of listing from Euronext Growth (Oslo) to Oslo Børs
Regulatory Filings
2021-06-24 English
Transfer of shares to Oslo Børs approved, prepared for accelerated growth
Regulatory Filings
2021-06-23 English
Oslo Børs – Resolution of transfer of listing from Euronext Growth to Oslo Børs – Gentian Diagnostics ASA
Regulatory Filings
2021-06-23 English
Gentian Diagnostics: Invitation to virtual presentation at 24 June
Report Publication Announcement
2021-06-18 English
Gentian Diagnostics: A long-term revenue ambition of NOK 1 billion from a portfolio of high-impact diagnostic tests
Investor Presentation
2021-06-18 English
Gentian Diagnostics: A long-term revenue ambition of NOK 1 billion from a portfolio of high-impact diagnostic tests
Earnings Release FY 2020
2021-06-18 English
Application for transfer of shares admitted to trading on Euronext Growth to to Oslo Børs
Delisting Announcement
2021-05-07 English
Gentian Diagnostics ASA – Application for admission to trading on Oslo Børs
Delisting Announcement
2021-05-07 English
Gentian Diagnostics ASA – conversion to public limited liability company registered
Regulatory Filings
2021-05-07 English
Minutes of Annual General Meeting
AGM Information
2021-05-04 English
Minutes of Annual General Meeting
AGM Information
2021-05-04 English
2021 Annual general meeting - proposal from the nomination committee
AGM Information
2021-04-29 English
Notice of Annual General Meeting
AGM Information
2021-04-22 English
Notice of Annual General Meeting
AGM Information
2021-04-22 English
Annual report 2020
Annual Report FY 2020
2021-04-16 English
Annual report 2020
Report Publication Announcement
2021-04-16 English
First quarter 2021 report
Interim / Quarterly Report Q1 2021
2021-04-16 English
First quarter 2021 report
Investor Presentation
2021-04-16 English
First quarter 2021 report
Report Publication Announcement
2021-04-16 English
Presentation of 2021 first quarter results for Gentian Diagnostics AS
Report Publication Announcement
2021-04-12 English
Publication of NT-proBNP patent application
Regulatory Filings
2021-02-18 English
4Q 2020 Results and preliminary annual report
Interim / Quarterly Report Q4 2020
2021-02-11 English
4Q 2020 Results and preliminary annual report
Investor Presentation
2021-02-11 English
4Q 2020 Results and preliminary annual report
Report Publication Announcement
2021-02-11 English
Presentation of 2020 fourth quarter results for Gentian Diagnostics AS
Report Publication Announcement
2021-02-05 English
SARS-CoV-2 antibody test moving to the next development phase
Regulatory Filings
2021-01-22 English